Skip to main content
Equibles

Squarepoint Ops LLC

Position in PGEN — Precigen, Inc.

CIK 1642575 NEW YORK, NY
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,013,650
+$1,770,742 QoQ
Shares Held
353,272
+462.8% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 210 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. PGEN ranks #75 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in PGEN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,013,650 353,272
2026-03-31 $242,908 62,767
2025-12-31 $330,546 79,078
2025-09-30 $75,472 22,940
2024-09-30 $15,433 16,246
2023-03-31 $187,918 177,282
2022-12-31 $27,255 17,931
2022-09-30 $93,704 44,200
2022-06-30 $104,850 78,247
2022-03-31 $190,781 90,418
2021-12-31 $368,414 99,303
2021-09-30 $257,324 51,568
2021-06-30 $1,047,581 160,672
2021-03-31 $357,811 51,932
2020-09-30 $124,890 35,683
2020-06-30 $440,237 88,224